Chemed Corporation $CHE Shares Purchased by Integrated Wealth Concepts LLC

Integrated Wealth Concepts LLC increased its stake in shares of Chemed Corporation (NYSE:CHE) by 25.6% during the third quarter, Holdings Channel reports. The institutional investor owned 22,100 shares of the company’s stock after acquiring an additional 4,509 shares during the period. Integrated Wealth Concepts LLC’s holdings in Chemed were worth $9,895,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its holdings in Chemed by 122.7% in the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after buying an additional 275,423 shares in the last quarter. William Blair Investment Management LLC boosted its stake in shares of Chemed by 13.6% during the 3rd quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock worth $172,435,000 after acquiring an additional 46,038 shares in the last quarter. Epoch Investment Partners Inc. boosted its stake in shares of Chemed by 29.4% during the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock worth $137,579,000 after acquiring an additional 69,878 shares in the last quarter. TD Asset Management Inc grew its holdings in shares of Chemed by 23.1% in the 3rd quarter. TD Asset Management Inc now owns 301,831 shares of the company’s stock worth $135,142,000 after acquiring an additional 56,546 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Chemed by 5.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 240,180 shares of the company’s stock worth $107,542,000 after acquiring an additional 12,810 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CHE. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $422.00 price objective (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Zacks Research downgraded Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Finally, Oppenheimer decreased their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $498.00.

Chemed Price Performance

Shares of CHE opened at $398.87 on Tuesday. Chemed Corporation has a 1-year low of $385.00 and a 1-year high of $623.60. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 21.71, a price-to-earnings-growth ratio of 1.59 and a beta of 0.47. The firm has a 50 day simple moving average of $440.69 and a 200-day simple moving average of $440.44.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The company had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. Chemed’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the company posted $6.83 EPS. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, equities analysts expect that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio is currently 13.06%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at $37,785,626.42. This trade represents a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.29% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.